Literature DB >> 27976800

Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.

Fan Zhang1, Lijuan Hu1, Junjun Wang1, Jian Chen1, Jie Chen2, Yumin Wang1.   

Abstract

BACKGROUND: Limited data are available for the diagnostic value, and for the diagnostic sensitivity and specificity of joint detection of serum lactate dehydrogenase (sLDH)/pleural fluid adenosine deaminase (pADA) and pleural fluid carcinoembryonic antigen (pCEA) in malignant pleural effusion (MPE).
METHODS: We collected 987 pleural effusion specimens (of which 318 were malignant pleural effusion, 374 were tubercular pleural effusion, and 295 were parapneumonic effusion specimens) from the First Affiliated Hospital of Wenzhou Medical University from July 2012 to March 2016. The pADA, sLDH, pleural fluid LDH (pLDH), serum C-reactive protein (sCRP), pleural fluid protein, pCEA, white blood cell (WBC), and red blood cell (RBC) were analyzed, and the clinical data of each group were collected for statistical analysis.
RESULTS: The level of sLDH/pADA, pCEA, and RBC from the MPE group was markedly higher than the tuberculosis pleural effusion (TB) group (Mann-Whitney U=28422.000, 9278.000, 30518, P=.000, .000, .000) and the parapneumonic pleural fluid group (Mann-Whitney U=5972.500, 7113.000, 36750.500, P=.000, .000, .000). The receiver operating characteristic curve ROC showed that the area under the ROC curve (AUC) (=0.924, 0.841) of pCEA and sLDH/pADA (cutoff=4.9, 10.6) were significantly higher than other markers for the diagnosis of MPE. Thus, joint detection of pCEA and sLDH/pADA suggested that the sensitivity, specificity, and AUC was 0.94, 81.70, and 94.32 at the cutoff 0.16 and diagnostic performance was higher than pCEA or sLDH/pADA.
CONCLUSION: Joint detection of sLDH/pADA and pCEA can be used as a good indicator for the identification of benign and MPE with higher sensitivity and specificity than pCEA or sLDH/pADA.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  malignant pleural effusion; pleural fluid carcinoembryonic antigen; serum lactate dehydrogenase/pleural fluid adenosine deaminase

Mesh:

Substances:

Year:  2016        PMID: 27976800      PMCID: PMC6817298          DOI: 10.1002/jcla.22106

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  12 in total

1.  Serum LDH and CA-125: Markers for Diagnosis of Ovarian Malignancy.

Authors:  F Deeba; S Khatun; M M Alam; S M Shahida
Journal:  Mymensingh Med J       Date:  2015-04

2.  Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.

Authors:  R Braunschweig; P Yan; I Guilleret; F Delacretaz; F T Bosman; A Mihaescu; J Benhattar
Journal:  Diagn Cytopathol       Date:  2001-03       Impact factor: 1.582

3.  Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.

Authors:  Fan Zhang; Lijuan Hu; Junjun Wang; Jian Chen; Jie Chen; Yumin Wang
Journal:  J Clin Lab Anal       Date:  2016-12-15       Impact factor: 2.352

4.  The comparative value of pleural fluid adenosine deaminase and neopterin levels in diagnostic utility of pleural tuberculosis.

Authors:  Filiz Koşar; Sibel Yurt; Burcu Arpınar Yiğitbaş; Barış Şeker; Hatice Kutbay Özçelik; Hafize Uzun
Journal:  Tuberk Toraks       Date:  2015

5.  Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.

Authors:  Seung-Myoung Son; Hye-Suk Han; Jin Young An; Kang Hyeon Choe; Ki Man Lee; Ki Hyeong Lee; So-Seul Kim; Yong-Moon Lee; Ho-Chang Lee; Hyung Geun Song; Ok-Jun Lee
Journal:  Pathology       Date:  2015-02       Impact factor: 5.306

Review 6.  Oesophageal atresia and tracheo-oesophageal fistula.

Authors:  A Goyal; M O Jones; J M Couriel; P D Losty
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-09       Impact factor: 5.747

7.  Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1.

Authors:  Gian Kayser; Ahmad Kassem; Wulf Sienel; Luzie Schulte-Uentrop; Dominik Mattern; Konrad Aumann; Elmar Stickeler; Martin Werner; Bernward Passlick; Axel zur Hausen
Journal:  Diagn Pathol       Date:  2010-04-12       Impact factor: 2.644

8.  Prognostic significance of pleural fluid data in patients with malignant effusion.

Authors:  Silvia Bielsa; Antonieta Salud; Montserrat Martínez; Aureli Esquerda; Antonio Martín; Francisco Rodríguez-Panadero; José M Porcel
Journal:  Eur J Intern Med       Date:  2007-11-08       Impact factor: 4.487

9.  Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).

Authors:  Akash Verma; John Abisheganaden; R W Light
Journal:  Lung       Date:  2015-12-17       Impact factor: 2.584

10.  Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.

Authors:  Yan Gu; Kan Zhai; Huan-Zhong Shi
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

View more
  7 in total

1.  Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.

Authors:  Fan Zhang; Lijuan Hu; Junjun Wang; Jian Chen; Jie Chen; Yumin Wang
Journal:  J Clin Lab Anal       Date:  2016-12-15       Impact factor: 2.352

2.  Diagnostic accuracy of cancer ratio for malignant pleural effusion: a systematic review and meta-analysis.

Authors:  Yan-Qiu Han; Lei Zhang; Li Yan; Pei-Heng Ouyang; Peng Li; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2019-10

3.  Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.

Authors:  Tian Tian; Jun Li; Wenjun Hu; Cuiling Sun; Jian Zhou
Journal:  J Clin Lab Anal       Date:  2019-04-15       Impact factor: 2.352

4.  Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.

Authors:  Junjun Wang; Jiali Fu; Qiang Shen; Fan Zhang; Yumin Wang; Ling Ling Wu
Journal:  J Clin Lab Anal       Date:  2019-07-03       Impact factor: 2.352

5.  Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.

Authors:  Ying Zhang; Xiaoou Li; Junhui Liu; Xueru Hu; Chun Wan; Rui Zhang; Yongchun Shen
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

6.  Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion.

Authors:  Mine Gayaf; Ceyda Anar; Mustafa Canbaz; Dursun Tatar; Filiz Güldaval
Journal:  Tanaffos       Date:  2021-03

7.  Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.

Authors:  Tiantian Zhang; Wei Liu; Li Li; Zou Jue; Chunhua Xu
Journal:  BMC Pulm Med       Date:  2022-08-10       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.